NW Biotherapeutics (NWBO) institutional ownership
NW Biotherapeutics · 13F, 2026Q2
| Managers holding | 8 |
|---|---|
| Shares held | 2,221,544 |
| Reported value | $413,559 |
| Quarter flows | 1 new, 1 added, 0 trimmed, 1 exited |
Top 8 holders
| Manager | Shares | Value | % of manager's 13F |
|---|---|---|---|
| COMPASS FINANCIAL MANAGEMENT LLC | 1,215,500 | $227,068 | 0.0% |
| KELLEHER FINANCIAL ADVISORS | 800,000 | $149,440 | 0.0% |
| VSM Wealth Advisory, LLC | 80,574 | $15,052 | 0.0% |
| Opus Capital Group, LLC | 60,150 | $11,000 | 0.0% |
| Ethos Financial Group, LLC | 39,070 | $6,329 | 0.0% |
| Williams Jones Wealth Management, LLC. | 25,000 | $4,670 | 0.0% |
| HANTZ FINANCIAL SERVICES, INC. | 250 | $0 | 0.0% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.0% |
Every holder, line by line, and the full history since 2013: yf.Client().holders("NWBO"). NWBO price history · All 13F data